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Abstract
Background: South Asians are more insulin resistant than Europeans, which cannot be fully explained by differences in
adiposity. We investigated whether differences in oxidative capacity and capacity for fatty acid utilisation in South Asians
might contribute, using a range of whole-body and skeletal muscle measures.
Methodology/Principal Findings: Twenty men of South Asian ethnic origin and 20 age and BMI-matched men of white
European descent underwent exercise and metabolic testing and provided a muscle biopsy to determine expression of
oxidative and lipid metabolism genes and of insulin signalling proteins. In analyses adjusted for age, BMI, fat mass and
physical activity, South Asians, compared to Europeans, exhibited; reduced insulin sensitivity by 26% (p= 0.010); lower
VO2max (40.666.6 vs 52.465.7 ml.kg
21.min21, p = 0.001); and reduced fat oxidation during submaximal exercise at the same
relative (3.7762.02 vs 6.5562.60 mg.kg21.min21 at 55% VO2max, p = 0.013), and absolute (3.4662.20 vs
6.0061.93 mg.kg21.min21 at 25 ml O2.kg
21.min21, p = 0.021), exercise intensities. South Asians exhibited significantly
higher skeletal muscle gene expression of CPT1A and FASN and significantly lower skeletal muscle protein expression of
PI3K and PKB Ser473 phosphorylation. Fat oxidation during submaximal exercise and VO2max both correlated significantly
with insulin sensitivity index and PKB Ser473 phosphorylation, with VO2max or fat oxidation during exercise explaining 10–
13% of the variance in insulin sensitivity index, independent of age, body composition and physical activity.
Conclusions/Significance: These data indicate that reduced oxidative capacity and capacity for fatty acid utilisation at the
whole body level are key features of the insulin resistant phenotype observed in South Asians, but that this is not the
consequence of reduced skeletal muscle expression of oxidative and lipid metabolism genes.
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Introduction
South Asians have a high risk of diabetes, particularly when they
migrate away from the Indian Subcontinent [1–4], with increased
insulin resistance likely to play a key role [5–9]. For a given BMI,
South Asians generally have higher percentages of body fat,
increased waist-to-hip ratios and increased truncal skinfold
thickness than European comparators [3,10] – although interest-
ingly increased visceral fat is not a consistent finding [7,11] – and
it has been suggested that this tendency to increased adiposity
and central fat distribution contributes to the increased insulin
resistance observed in this group. However, additional studies
have shown that even after adjustment for BMI, waist-hip-
ratio, and skin-fold thickness, insulin levels (both fasting and
post glucose-load) remain significantly higher in South Asians
[11,12]. Furthermore, even when South Asian men are closely
matched for BMI, waist-to-hip ratios and visceral fat areas with
European men, they exhibit substantially increased insulin
resistance [11]. In addition, South Asians develop diabetes and
metabolic disturbances associated with insulin resistance at lower
BMI values than Europeans [13]. Thus, it appears that the
increased insulin resistance in South Asians cannot be fully
PLoS ONE | www.plosone.org 1 December 2010 | Volume 5 | Issue 12 | e14197
explained by differences in adiposity and/or abdominal fat
accumulation.
Accumulation of lipid within skeletal muscle – particularly of
active lipid intermediates such as long chain fatty acyl-CoA,
diacylglycerol and ceramide – is likely to play a causal role in
insulin resistance [14]. It has been reported that South Asians have
30% higher intramuscular triglyceride (IMTG) concentrations
than BMI-matched Europeans [11]. Although it is now generally
accepted that IMTG per se (as opposed to lipid intermediates) is
unlikely to play a direct role in insulin resistance, IMTG does
provide a useful marker of cytosolic lipid accumulation [14], thus
the observation of elevated IMTG in South Asians is suggestive of
a deficiency in skeletal muscle lipid metabolism. Accumulating
evidence indicates that defects in skeletal muscle oxidative capacity
and low rates of skeletal muscle lipid oxidation are likely to
contribute to skeletal muscle lipid accumulation and consequent
insulin resistance [15–17]. However, Nair and colleagues reported
that middle-aged non-diabetic Asian Indians had increased
skeletal muscle expression of genes involved with oxidative
phosphorylation and the citrate cycle and increased capacity for
mitochondrial ATP production than matched Americans of
European descent, despite being more insulin resistant, concluding
that mitochondrial dysfunction could not account for the Asian
Indians’ greater insulin resistance [9]. However, these data may
not tell the whole story. In contrast to the skeletal muscle data
indicating increased mitochondrial capacity, the available evi-
dence at the whole-body level indicates that South Asians have
lower maximal oxygen uptake (VO2max) values – an index of
oxidative capacity at the whole-body level – than matched
European comparators [12,18] and VO2max is a strong indepen-
dent predictor of whole body insulin sensitivity [19,20]. However,
while it is known that cardiorespiratory fitness is closely associated
with skeletal muscle lipid oxidative capacity [21–23], it is not
known whether capacity for lipid oxidation is reduced in South
Asians compared to Europeans, or whether these factors
contribute to South Asians’ increased insulin resistance.
Thus, in order to gain further insight into the potential role of
altered capacity for lipid oxidation in mediating the South Asian
insulin resistant phenotype, we undertook a detailed investigation
of oxidative capacity and capacity for fatty acid utilisation in
matched South Asian and European men using a range of whole-
body and skeletal muscle measures. In addition, we characterised
the expression of insulin signalling molecules in skeletal muscle
biopsies, to determine whether alterations in key signalling
proteins were associated with alterations in oxidative capacity
and/or insulin sensitivity.
Methods
Subjects and recruitment
Twenty men of South Asian ethnic origin and 20 men of white
European decent, individually matched for age (65 years) and
BMI (62 kg.m22) were recruited via a study website and local
advertising. Data from one European man was excluded as he was
subsequently discovered to have diabetes: the final study group
therefore contained 20 South Asian and 19 European men.
Anthropometric, physiological and biochemical characteristics of
the volunteers included in the analyses are shown in Tables 1, 2
and 3. All volunteers currently resided in Glasgow; 18 of the
European and 4 of the South Asian men had lived in the UK all of
their lives. Of the 16 South Asians born outside the UK, mean (6
SD) duration of UK residence was 2.565.0 years. All participants
reported low to moderate levels of physical activity (,2 hours of
planned exercise per week and physically inactive job), and were
non-smokers, aged 18–40 years, in generally good health, with
blood pressure ,160/90 mmHg, and no known history of
diabetes or cardiovascular disease. Other than one European
using steroid and b2 agonist inhalers for asthma and topical
steroids for eczema and another European using topical steroids
for eczema, no volunteer was taking any medications. The study
was approved by the North Glasgow NHS Trust Research Ethics
Committee and was conducted according to the principles
Table 1. Anthropometric data for European and South Asian men.
South Asians
(n=20)
Europeans
(n=19)
P
(unadjusted)
P (age and BMI
adjusted)
P (age, BMI and fat
mass adjusted)
Age (years) 26.963.9 24.565.5 0.12 - -
BMI (kg.m22) 23.662.9 22.662.7 0.31 - -
Body mass (kg) 71.8610.1 72.568.8 0.82 0.13 0.034
Height (cm) 174.4±7.1 179.0±6.8 0.046 0.11 0.028
Total fat mass (kg) 18.4±5.3 13.6±5.2 0.007 ,0.0005 -
Trunk fat mass (kg) 10.0±3.3 7.1±3.3 0.009 ,0.0005 0.520
Arm fat mass (kg) 1.4±0.5 1.0±0.5 0.02 0.008 0.606
Leg fat mass (kg) 6.3±1.6 5.0±1.5 0.009 0.004 0.618
Fat-free mass (kg) 53.4±6.6 58.9±5.9 0.010 0.001 0.034
Total lean mass (kg) 50.0±5.8 56.3±5.6 0.001 ,0.0005 0.009
Trunk lean mass (kg) 22.7±2.8 26.4±2.6 ,0.0005 ,0.0005 0.003
Arm lean mass (kg) 6.260.8 6.560.9 0.25 0.08 0.327
Leg lean mass (kg) 17.5±2.3 19.5±2.1 0.007 0.002 0.026
Waist circumference (cm) 82.367.5 78.866.8 0.14 0.30 0.778
Hip circumference (cm) 97.365.8 96.661.1 0.69 0.59 0.463
Values are mean 6 SD.
doi:10.1371/journal.pone.0014197.t001
Insulin Resistance in Asians
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expressed in the Declaration of Helsinki. All participants gave
written informed consent.
Body composition assessment
Dual X-Ray Absorptiometry (DEXA) scans (LUNAR Prodigy
DEXA scanner, GE Healthcare Diagnostic Imaging, Slough, UK)
were used to determine body composition and fat distribution.
Height, body mass, waist and hip circumferences were also
determined using standard protocols [24].
Exercise tests
Exercise tests, undertaken following a 12-hour overnight fast,
were performed to determine VO2max and rates of fat oxidation
during sub-maximal exercise. Following an exercise tolerance test
to ensure no cardiovascular contraindications to maximal exercise
[25], VO2max was assessed using the modified Taylor incremental
treadmill test protocol [26], with 1-minute expired air samples
taken continuously using Douglas Bags and heart rate monitored
by short-range telemetry. Achievement of VO2max was verified by
volitional exhaustion together with a rate of perceived exertion
(RPE) of 19–20 [27], a respiratory exchange ratio .1.15, and
heart rate within 10 beats of age-predicted maximum.
On a separate day subjects underwent a submaximal incre-
mental treadmill test at 5.5 km.h21, with an initial gradient
calculated to elicit an oxygen uptake of ,40% VO2max. Gradient
increased by 1% every 4 minutes, until an RPE of 15–16 was
achieved. Expired air, heart rate and RPE were taken during the
final minute of each stage. Fat and carbohydrate oxidation rates at
Table 2. Fitness and physical activity data for European and South Asian men.
South Asians
(n =20)
Europeans
(n =19)
P
(unadjusted)
P (age and BMI
adjusted)
P (age, BMI and fat
mass adjusted)
VO2max
(ml.kg21.min21)
40.6±6.6 52.4±5.7 ,0.0005 ,0.0005 0.001
VO2max
(ml.kg21 fat-free mass.min21)
54.1±6.6 64.3±5.8 ,0.0005 ,0.0005 0.001
Physical activity*
(total MET-mins.day21)
2546114 2906229 0.75 0.46 0.59
Values are mean 6 SD.
*statistical analysis performed on log transformed data.
doi:10.1371/journal.pone.0014197.t002
Table 3. Metabolic data for European and South Asian men.
South Asians
(n =20)
Europeans
(n =19)
P
(unadjusted)
P (age and BMI
adjusted)
P (age, BMI and fat
mass adjusted)
Fasting glucose*
(mmol.l21)
5.1460.47 5.2460.52 0.53 0.50 0.94
Fasting insulin*
(mU.l21)
6.56±3.53 5.39±4.20 0.11 0.17 0.023
Fasting NEFA*
(mmol.l21)
0.4160.13 0.4460.57 0.85 0.99 0.85
2 hour insulin*
(mU.l21)
46.6±29.6 27.5±5.3 0.017 0.031 0.043
Insulin AUC*
(mU.l21.min)
6325±720 4374±661 0.036 0.045 0.099
Glucose AUC*
(mU.l21.min)
833632 885639 0.35 0.46 0.74
NEFA AUC*
(mU.l21.min)
30.862.1 31.163.9 0.38 0.39 0.60
Insulin sensitivity index{ 5.89±2.93 7.96±3.49 0.048 0.047 0.012
Fasting total cholesterol (mmol.l21) 4.4660.89 4.0760.85 0.17 0.23 0.37
Fasting HDL cholesterol (mmol.l21) 1.08±0.22 1.37±0.20 ,0.0005 ,0.0005 0.001
Fasting TG*
(mmol.l21)
1.1860.65 0.8760.56 0.054 0.11 0.13
Resting metabolic rate
(kJ.kg fat-free mass21.day21)
114.169.0 118.6610.8 0.170 0.378 0.059
Resting fasted fat oxidation
(mg.kg21 fat-free mass.min21)
1.4760.44 1.3860.43 0.548 0.510 0.862
Values are mean 6 SD.
*statistical analysis performed on log transformed data,
{statistical analysis performed on square-root transformed data.
doi:10.1371/journal.pone.0014197.t003
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each exercise stage was determined from VO2 and VCO2
measurements in expired air by indirect calorimetry [28]. As
skeletal muscle capacity for mitochondrial fat oxidation correlates
strongly with fat oxidation during sub-maximal exercise [21], this
test was used to provide an index of skeletal muscle fat oxidative
capacity.
Determination of habitual physical activity and diet
Habitual physical activity was assessed using the long form of
the International Physical Activity Questionnaire [29] and
habitual diet was assessed using a 120-item food-frequency
questionnaire [30].
Metabolic assessment and muscle biopsy
For these measurements volunteers attended the laboratory
after 12-hour overnight fast, and at least a 60-hour abstention
from planned exercise. Following a 10-minute rest lying on a
couch, a 20-minute expired air sample was collected using a
ventilated hood system (Oxycon Pro, Jaeger, Germany). Metabolic
rate and rates of fat and carbohydrate oxidation were calculated
by indirect calorimetry [28], assuming urinary nitrogen excretion
to be 0.11 mg.kg21.min21 [31,32]. A fasting blood sample was
then taken, followed by a muscle biopsy from the vastus lateralis of
the right leg, 20 cm above the patella, under local anaesthesia
using a ‘semi-open’ technique [33]. Visible fat and connective
tissue was removed with sterile forceps and samples were divided
in six pieces. Four pieces were immediately snap-frozen in liquid
N2, the remaining two pieces were incubated for 15 minutes in
Krebs Ringer Hepes buffer (118 mM NaCl, 25 mM Hepes-
NaOH, pH 7.4, 5 mM NaHCO3, 4.7 mM KCl, 1.2 mMMgSO4,
1.2 mM NaH2PO4, 2.5 mM CaCl2, 5mM glucose, 0.1% (w/v)
bovine serum albumin) at 37uC, gassed with O2 prior to
incubation for 10 min in the presence or absence of 10 nM
human soluble insulin (Actrapid, Novo Nordisk), before snap-
freezing in liquid N2 prior to homogenisation for immunoblotting
analysis. The 10 nM insulin dose was chosen to maximally
stimulate insulin signalling [34]. Subjects then consumed 75 g
glucose orally in a 300 ml volume, with further blood samples
taken at 30-minute intervals for 120 minutes.
Plasma analyses
Blood was collected into potassium EDTA tubes, placed on ice,
separated within 15 minutes and stored at -80uC until analysis.
Glucose, TG, non-esterified fatty acid (NEFA), total cholesterol,
and HDL cholesterol concentrations were determined by
enzymatic colorimetric methods using commercially available kits
(Roche Diagnostics Gmbh, Mannheim, Germany; Wako Chem-
icals GmbH, Neuss, Germany and Randox Laboratories Ltd., Co.
Antrim, Ireland). Insulin was determined using a commercially
available ELISA with ,0.01% cross-reactivity with pro-insulin
(Mercodia AB, Uppsala, Sweden). Adiponectin, leptin, IL-6 and
TNFa concentrations were also determined by ELISA (R&D
Systems Europe, Abingdon, United Kingdom).
Determination of skeletal muscle expression of oxidative
and lipid metabolism genes
RNA was extracted from muscle using an E.Z.N.A. Tissue
RNA kit (Omega Bio-Tek, Inc., Norcross, GA) according to the
manufacturer’s protocol using Precellys Ceramic Homogenisation
beads (CK14, PEQLAB Ltd, Farnborough, UK) and a Hybaid
Ribolyser (Thermo Scientific, Loughborough, United Kingdom).
cDNA was synthesised using an Applied BioSystems High
Capacity cDNA Reverse Transcription kit (Life Technologies
Corporation, Carlsbad, CA) with random hexamers according to
the manufacturers protocol, but doubling the volumes to increase
yield. Quantitative polymerase chain reaction (qPCR) assays were
designed for each transcript (Table S1) using the Roche Universal
ProbeLibrary Assay Design Center (http://www.roches-applied-
science.com/) and mRNA expression levels of transcripts were
determined as described previously [35].
Determination of skeletal muscle mitochondrial DNA
(mtDNA) to nuclear DNA (nDNA) ratio
DNA was extracted from muscle using a QIAamp DNA Mini
Kit (Qiagen Ltd., Crawley, United Kingdom) according to the
manufacturer’s protocol (including the RNase treatment) using
Precellys Ceramic Homogenisation beads (CK14, PEQLAB Ltd,
Farnborough, UK) and a Hybaid Ribolyser (Thermo Scientific,
Loughborough, United Kingdom). qPCR assays were designed,
using the Roche Universal ProbeLibrary Assay Design Center, for
the mitochondrial genome overlapping two neighbouring genes
(tRNA leucine 1 and NADH dehydrogenase 1) and the nuclear
genome using the b2-adrenergic receptor gene promoter (Table
S1). Relative DNA levels were determined in a similar fashion to
the mRNA expression levels.
Determination of skeletal muscle insulin signalling
protein expression
Muscle biopsies were homogenised in 8 volumes of homogeni-
sation buffer (50 mM Tris-HCl, pH 7.4 at 4uC, 250 mM sucrose,
1 mM EDTA, 1 mM EGTA, 5 mM NaF, 5 mM Na4P2O7,
1 mM dithiothreitol, 1 mM Na3VO4, 0.1 mM benzamidine,
0.1 mM phenylmethylsuplhonyl fluoride, 5 mg.ml21 soybean
trypsin inhibitor) by 20 passes in a Dounce homogeniser at 4uC.
Homogenates were centrifuged (350,000 g, 30 min, 4uC) to obtain
cytosolic supernatant fractions. Pellets were re-suspended in 150 ml
homogenisation buffer supplemented with 1% (v/v) NP-40 and
incubated on ice for 30 min prior to centrifugation (100,000 g,
30 min, 4uC) to obtain microsomal supernatant fractions.
Cytosolic and microsomal protein concentrations were assessed
according to the method of Bradford [36].
Equal amounts of cytosolic/microsomal fraction protein were
resolved by SDS-PAGE and subjected to immunoblotting using
rabbit anti-IRS-1 (New England Biolabs, Hitchin, Hertfordshire,
UK), mouse anti-phosphatidylinositol 39-kinase (PI3K) p85
subunit (BD Biosciences, Oxford, Oxfordshire, UK), rabbit anti-
PI3K p110b subunit and anti-PKCb1 (Santa Cruz Biotechnology,
Santa Cruz, CA, USA), mouse anti-glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) (Applied Biosystems, Warrington, Che-
shire, UK), rabbit anti-PKB and anti-phospho-PKB Ser473 (New
England Biolabs) antibodies. Blots were scanned and band
intensity analysed using Image J software, normalised by
comparison with an internal control human muscle lysate.
Data analysis
Insulin sensitivity was calculated from fasting and post-glucose
plasma glucose and insulin concentrations using the Insulin
Sensitivity Index (ISI) derived by Matsuda and DeFronzo – i.e.
10000/![(fasting glucose x fasting insulin) x (mean glucose during
OGTT x mean insulin during OGTT)], which correlates highly
with whole-body glucose disposal rate during a euglyaemic
hyperinsulinaemic clamp [37].
Data were analysed using Statistica (version 6.0, StatSoft Inc.,
Oklahoma) and Minitab (version 14, Minitab Inc., Pennsylvania).
Data were tested for normality using the Ryan-Joiner normality
test and transformed as appropriate (determined using Box-Cox
Insulin Resistance in Asians
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plots). General linear models were used to compare data between
European and South Asian groups. As age and BMI were not
identical between the two groups (although not significantly
different), statistical analysis was undertaken both unadjusted and
adjusted for age and BMI. Further adjustment was undertaken as
appropriate to determine independence from potential confound-
ers. Regression analysis was used to determine relationships
between variables. A homogeneity-of-slopes regression model was
used to identify whether the slope of relationships between
variables differed between the South Asian and European groups.
Where the slopes differed significantly between the two groups,
univariate regressions were performed for the South Asian and
European groups separately, otherwise univariate regressions were
performed on the combined group to maximize statistical power.
Partial correlations were undertaken where appropriate to adjust
for the effect of potential confounders (such as age, BMI, fat mass
and physical activity level) on relationships between variables.
Statistical significance was accepted at the p,0.05 level.
Results
Anthropometric characteristics
Anthropometric data are presented in Table 1. There were no
significant differences in age, BMI or body mass between South
Asians and Europeans, but the South Asians were shorter; had
greater total, trunk, arm and leg fat mass; and lower fat-free mass,
and total, trunk and leg lean mass than the Europeans. These
differences persisted after adjustment for age and BMI. Further
adjustment for fat mass abolished differences in trunk, arm and leg
fat between groups, indicating no significant differences in regional
distribution between Europeans and South Asians.
Physical activity and dietary data
Neither habitual physical activity levels (Table 2), nor energy
(South Asians: 8.862.0 MJ.day21, Europeans: 9.462.0 MJ.day21,
p = 0.41), fat (71618 g.day21 vs 80626 g.day21, p = 0.19), carbo-
hydrate (290690 g.day21 vs 260650 g.day21, p = 0.20) or protein
(87617 g.day21 vs 98625 g.day21, p = 0.12) intake differed
significantly between the South Asian and European groups.
However, self-reported alcohol intake was significantly higher in
the Europeans (South Asians: 367 g.day21, Europeans:
20617 g.day21, p = 0.0002).
Exercise test data
Fitness and physical activity data are presented in Table 2 and
Figures 1 and 2. South Asians had significantly lower VO2max
values than Europeans, irrespective of the units of expression.
These differences remained significant after adjustment for age,
BMI and fat mass. South Asians had lower rates of fat oxidation
than Europeans during sub-maximal exercise, whether intensity
was expressed in absolute terms (i.e. ml.kg21.min21) (Figure 1A) or
relative to VO2max (Figure 2A). This difference persisted after
adjustment for age, BMI and fat mass. Carbohydrate oxidation
rates in South Asians during sub-maximal exercise were similar to
Europeans at the same relative exercise intensity (Figure 2B), and
higher at the same absolute exercise intensity (Figure 1B).
Metabolic data
Metabolic data are presented in Table 3 and Figures 3 and 4. ISI
andHDL-cholesterol were lower in South Asians than Europeans in
unadjusted analysis; this persisted after adjustment for age, BMI and
fat mass. Insulin AUC and 2-hour insulin were higher in South
Asians than Europeans in unadjusted analysis and after adjustment
for age and BMI. 2-hour insulin remained higher after further
adjustment for fat mass. Although not different between groups in
the unadjusted analysis, fasting insulin was higher in South Asians
than Europeans after adjustment for age, BMI and fat mass.
Adjustment for trunk fat mass, instead of total fat mass, did not alter
the findings (data not shown). The significant difference in ISI
(p= 0.044) and HDL-cholesterol concentrations (p= 0.004) be-
tween South Asian and Europeans was retained when data were
adjusted for percentage body fat, rather than total fat mass, but with
this adjustment the difference in fasting (p= 0.12) and 2-hour
(p= 0.13) insulin concentrations between groups was lost. When ISI
values were further adjusted for VO2max, or for the rate of fat
oxidation fat oxidation during sub-maximal exercise at 55%
VO2max, the significant difference between South Asian and
European groups was abolished (p= 0.16 and 0.12, respectively).
Resting metabolic rate and rate of fat oxidation (expressed per kg
fat-free mass) did not differ between groups.
Skeletal muscle mtDNA to nDNA ratio
The mtDNA to nDNA ratio in skeletal muscle did not differ
between South Asians and Europeans (mean (95% CI) South Asians:
0.94 (0.71 to 1.21), Europeans: 1.13 (0.82 to 1.49), p= 0.39).
Figure 1. Fat oxidation (A) and carbohydrate oxidation (B) during incremental submaximal exercise. Intensity expressed in terms of
absolute oxygen uptake (i.e. ml.kg21.min21). P values shown are for the main-effect difference between European and South Asian groups, either
unadjusted, or adjusted for age, BMI and fat mass.
doi:10.1371/journal.pone.0014197.g001
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Skeletal muscle expression of oxidative and lipid
metabolism genes
Expression of oxidative and lipid metabolism genes in skeletal
muscle is shown in Table 4. Expression of carnitine palmitoyl-
transferase 1A (CPT1A) was 1.79-fold greater (p = 0.023) and
expression of fatty acid synthase (FASN) was 1.96-fold greater
(p = 0.036) in South Asians than Europeans.
Skeletal muscle insulin signalling protein expression
Insulin signalling protein expression data (and n for each
variable) are shown in Table 5. Representative blots are shown in
Figure 5. Technical difficulties limited these data to a sub-set of
participants, and one outlier (.9 SDs from mean) for p110b PI3K
subunit expression was excluded as its inclusion prevented data
normalization. Expression of IRS-1, PI3K (p110b), PKB and
PKCb1 was principally observed in the soluble cytosolic fraction,
whereas expression of PI3K (p85) was principally observed in the
microsomal fraction (Figure 5). Cytosolic IRS-1 protein expression
was significantly lower in South Asians than Europeans in
unadjusted analysis, but this difference was abolished on
Figure 2. Fat oxidation (A) and carbohydrate oxidation (B) during incremental submaximal exercise. Intensity expressed relative to each
individual’s maximal oxygen uptake (i.e. percentage VO2max). P values shown are for the main-effect difference between European and South Asian
groups, either unadjusted, or adjusted for age, BMI and fat mass.
doi:10.1371/journal.pone.0014197.g002
Figure 3. Plasma insulin (A), glucose (B) and NEFA (C)
responses to a 75 g oral glucose load. Summary measures of
these responses are presented in Table 3.
doi:10.1371/journal.pone.0014197.g003
Figure 4. Individual insulin sensitivity index values for the
European and South Asian men. Horizontal bars denote mean
values. P values shown are for the difference between European and
South Asian groups, either unadjusted, or adjusted for age, BMI and fat
mass.
doi:10.1371/journal.pone.0014197.g004
Insulin Resistance in Asians
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Table 4. Oxidative and lipid metabolism gene expression in skeletal muscle in European and South Asian men.
South Asians
(n =20)
Europeans
(n =19) P (unadjusted)
P (age and BMI
adjusted)
P (age, BMI and fat
mass adjusted)
CD36 1.15
(0.94 to 1.41)
1.00
(0.81 to 1.23)
0.343 0.210 0.168
CPT1A 1.79
(1.32 to 2.43)
1.00
(0.69 to 1.46)
0.023 0.013 0.007
CPT1B 1.22
(0.89 to 1.68)
1.00
(0.71 to 1.40)
0.406 0.244 0.088
CPT2 1.16
(1.00 to 1.34)
1.00
(0.74 to 1.36)
0.388 0.282 0.459
HADHA 1.25
(0.98 to 1.59)
1.00
(0.77 to 1.30)
0.233 0.078 0.049
HADHB 1.23
(0.96 to 1.57)
1.00
(0.75 to 1.33)
0.296 0.356 0.538
ACACA 1.32
(0.86 to 2.04)
1.00
(0.7 to 1.43)
0.342 0.201 0.109
ACACB 1.25
(0.84 to 1.86)
1.00
(0.69 to 1.46)
0.422 0.183 0.141
CS 1.10
(0.84 to 1.44)
1.00
(0.79 to 1.27)
0.606 0.303 0.066
CS (long transcript) 1.29
(1.04 to 1.6)
1.00
(0.8 to 1.26)
0.122 0.061 0.031
CS (short transcript) 1.09
(0.79 to 1.5)
1.00
(0.73 to 1.37)
0.712 0.323 0.064
COX1 1.07
(0.72 to 1.59)
1.00
(0.69 to 1.44)
0.805 0.515 0.447
FASN 1.96
(1.19 to 3.25)
1.00
(0.72 to 1.39)
0.036 0.025 0.111
FADS3 1.65
(1.19 to 2.28)
1.00
(0.64 to 1.56)
0.082 0.037 0.023
Values are mean (95% CI), expressed relative to mean value in European group.
doi:10.1371/journal.pone.0014197.t004
Table 5. Skeletal muscle insulin signalling protein expression in South Asian and European men.
South Asians Europeans P (unadjusted)
P (age and BMI
adjusted)
P (age, BMI and fat
mass adjusted)
IRS-1
(n = 8 South Asians, 7 Europeans)
0.35
(0.13 to 0.56)
1.00
(0.50 to 1.50)
0.028 0.699 0.699
PI3K, p85 subunit
(n = 8 South Asians, 8 Europeans)
0.51
(0.28 to 0.75)
1.00
(0.84 to 1.16)
0.005 0.079 0.049
PI3K, p110b subunit
(n = 5 South Asians, 14 Europeans)
1.05
(0.82 to 1.28)
1.00
(0.78 to 1.22)
0.800 0.281 0.159
PKB*
(n = 16 South Asians, 12 Europeans)
0.51
(0.36 to 0.71)
1.00
(0.57 to 1.75)
0.041 0.003 0.054
Basal PKB Ser473 phosphoryation*
(n = 14 South Asians, 11 Europeans)
0.38
(0.27 to 0.52)
1.00
(0.74 to 1.38)
,0.0005 ,0.0005 0.019
Insulin-stimulated PKB Ser473 phosphoryation*
(n = 14 South Asians, 11 Europeans)
1.58
(1.22 to 2.05)
1.63
(1.07 to 2.48)
0.889 0.419 0.287
Cytosolic PKCb1
(n = 8 South Asians, 9 Europeans)
0.94
(0.61 to 1.27)
1.00
(0.64 to 1.37)
0.813 0.739 0.759
Microsomal PKCb1
(n = 8 South Asians, 9 Europeans){
0.17
(0.11 to 0.24)
0.20
(0.05 to 0.46)
0.824 0.907 0.734
Values are mean (95% CI), expressed relative to mean value in European group.
*statistical analysis performed on log transformed data,
{statistical analysis performed on square-root transformed data.
doi:10.1371/journal.pone.0014197.t005
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adjustment (Table 5). Microsomal expression of the PI3K p85
subunit was ,50% lower in South Asians than Europeans; this
remained significant after adjustment for age, BMI and fat mass
(Table 5). Cytosolic PKB protein expression was also ,50% lower
in South Asians than Europeans. This difference remained after
adjustment for age and BMI, and became borderline significant
after further adjustment for fat mass (Table 5, p = 0.054). Neither
protein expression of the PI3K p110b subunit, nor protein
expression of cytosolic or microsomal PKCb1 differed significantly
between groups. Ex vivo stimulation of muscle with insulin had no
effect on the expression of IRS-1, PI3K (p85 or p110b), PKB or
PKCb1 in microsomal or soluble cytosolic fractions (Figure 5).
Basal PKB phosphorylation at Ser473 was over 60% lower in
South Asians than Europeans; this remained significant after
adjustment (Table 5). Insulin-stimulated PKB phosphorylation did
not differ significantly between groups (Table 5). The ratio of PKB
phosphorylation at Ser473 to PKB expression did not differ
significantly between South Asians and Europeans under either
basal or insulin-stimulated conditions.
Anthropometric and physiological correlates with insulin
sensitivity index and insulin signalling protein expression
The regression slopes for these relationships did not differ
significantly between South Asians and Europeans so data are
presented for the combined group. As expected, square-root ISI
correlated significantly with BMI (r =20.373, p = 0.019), waist
circumference (r =20.387, p = 0.015) and trunk fat mass
(r =20.359, p= 0.025). Square-root ISI correlated significantly
with height (r = 0.329, p= 0.041). None of the other measured
body composition variables significantly correlated with square-
root ISI.
In unadjusted univariate correlations, VO2max, expressed in
ml.kg21.min21 (r = 0.399, p = 0.012) or ml.kg21 fat-free mass.-
min21 (r = 0.352, p= 0.028) correlated significantly with square-
root ISI. In addition, fat oxidation during sub-maximal exercise at
55% VO2max, expressed in mg.kg
21.min21 (r = 0.423, p= 0.011)
(Figure 6) or in mg.kg21 fat-free mass.min21 (r = 0.409, p = 0.015),
and fat oxidation at an absolute VO2 of 25 mg.kg
21.min21
(r = 0.370, p = 0.029) correlated significantly with square-root ISI.
Adjustment for age, BMI, fat mass and physical activity slightly
attenuated the relationships. However, even after adjustment
significant relationships were observed between square root ISI,
and VO2max expressed in ml.kg
21 fat-free mass.min21 (r = 0.318,
p = 0.049) and fat oxidation during submaximal exercise at 55%
VO2max, expressed in mg.kg
21.min21 (r = 0.337, p = 0.048) or in
mg.kg21 fat-free mass.min21 (r = 0.358, p= 0.035). Thus, inde-
pendent of age, body composition and physical activity level,
VO2max or fat oxidation during submaximal exercise explained
10-13% of the variance (i.e. r2) in square-root ISI.
Neither fat oxidation rate at rest nor resting metabolic rate
(however expressed) correlated significantly with square-root ISI.
Figure 5. Insulin signalling molecule expression in subjects.
Soluble cytosolic (C) and microsomal (M) fractions were prepared from
muscles incubated ex vivo in the presence or absence of insulin.
Fractions were resolved by SDS-PAGE and subjected to immunoblotting
with the antibodies indicated. Representative blots are shown from one
South Asian and one European subject.
doi:10.1371/journal.pone.0014197.g005
Figure 6. Relationship between exercise fat oxidation and
insulin sensitivity index (A) and basal PKB Ser473 phosphor-
yation (B).
doi:10.1371/journal.pone.0014197.g006
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In addition, fat oxidation rate at rest did not correlate significantly
with fat oxidation rates during exercise (however expressed).
Basal PKB phosphorylation at Ser473 correlated significantly
with square-root ISI (r = 0.407, p= 0.044) (Figure 7), and indices
of body composition (significant negative correlations with total,
arm, leg and trunk fat mass, and waist (r =20.401 to 20.440, all
p,0.05); and significant positive correlations with fat-free mass
and total, leg and trunk lean mass (r = 0.538 to 0.546, all p,0.05)).
In addition, basal PKB Ser473 phosphorylation was strongly
correlated with VO2max, expressed in ml.kg
21.min21 (r = 0.634,
p = 0.001) or ml.kg21 fat-free mass.min21 (r = 0.539, p = 0.005);
fat oxidation during exercise at 55% VO2max, expressed in
mg.kg21.min21 (r = 0.475, p = 0.025) (Figure 4); and fat oxidation
at an absolute VO2 of 25 mg.kg
21.min21 (r = 0.588, p = 0.004).
There was a borderline significant correlation between basal
Ser473 PKB phosphorylation and fat oxidation during exercise at
55% VO2max, expressed in mg.kg
21 fat-free mass.min21
(r = 0.406, p= 0.061). Although there was no relationship between
basal and insulin-stimulated Ser473 PKB phosphorylation
(r = 0.080, p = 0.705), and insulin-stimulated Ser473 PKB phos-
phorylation did not differ significantly between the South Asian
and European groups, insulin-stimulated PKB phosphorylation at
Ser473 also correlated significantly with square-root ISI (r = 0.427,
p = 0.033) and indices of body composition (negative correlations
with total and trunk fat mass, BMI and waist (r =20.456 to –
0.533, all p,0.05)). However, insulin-stimulated Ser473 PKB
phosphorylation did not correlate significantly with VO2max or fat
oxidation during exercise, however expressed. None of the other
measured insulin signalling proteins correlated significantly with
square-root ISI, or any indices of body composition, but protein
expression of IRS-1 correlated significantly with VO2max,
expressed in ml.kg21.min21 (r = 0.677, p= 0.006) or ml.kg21 fat-
free mass.min21 (r = 0.649, p = 0.009).
Relationships between skeletal muscle and whole-body
metabolism
Homogeneity-of-slopes regression analysis revealed significant
interactions between South Asians and Europeans in the slope of
the relationships between expression of a number of skeletal
muscle genes and whole-body indices. South Asian and European
groups were therefore considered separately in these analyses.
There was a significant negative correlation between square-root
ISI and log CPT1A gene expression in South Asians (r =2 0.533,
p = 0.016), but not in Europeans (r = 0.035, p= 0.886). Expression
of none of the other measured oxidative and lipid metabolism
genes correlated significantly with square-root ISI in either group.
Figure 8 shows the relationships between fat oxidation during
exercise at 55% VO2max, expressed in mg.kg
21.min21 and skeletal
muscle expression of oxidative and lipid metabolism genes in the
South Asian and European groups. In general, positive associa-
tions were seen between skeletal muscle gene expression and fat
oxidation during exercise in the Europeans, with significant
positive correlations observed with fat oxidation during exercise
and skeletal muscle CS, FASD3, HADHA, CD36, ACACA,
ACACB, CPT1A and COX1 gene expression (r = 0.487 to 0.697,
all p,0.05). In contrast negative association were seen in South
Asians between fat oxidation during exercise and skeletal muscle
CS, FADS3, HADHA, ACACA, ACACB and CPT1A
(r =20.519 to 20.779, all p,0.05). For 10 of the 12 genes
investigated, a significant interaction was observed between the
European and South Asian groups in the relationship between
skeletal muscle gene expression and fat oxidation during exercise
(Figure 8). Expressing fat oxidation during exercise in mg.kg21 fat-
free mass.min21 yielded essentially the same results.
There were no significant correlations between skeletal muscle
expression of any oxidative and lipid metabolism gene and
VO2max in either the South Asian or the European group.
Discussion
We report four main novel findings from this study: 1) that
South Asians oxidised less fat during submaximal exercise than
Europeans, a difference which persisted after adjustment for age,
BMI and fat mass; 2) that South Asians had reduced skeletal
muscle expression of key insulin signalling proteins than
Europeans; 3) that VO2max and fat oxidation during submaximal
exercise correlated significantly with whole-body insulin sensitivity
(and PKB Ser473 phosphorylation), independently of age and
body composition; and 4) that the relationship between fat
oxidation during submaximal exercise and skeletal muscle
expression of oxidative and lipid metabolism genes differed
between South Asians and Europeans. Collectively, these data
indicate that reduced oxidative capacity and capacity for fatty acid
utilisation at the whole-body level are key features of the insulin
resistant phenotype observed in South Asians, but that this is not
the consequence of reduced skeletal muscle expression of oxidative
and lipid metabolism genes.
Low VO2max values are often [19,20,38], but not always [38],
associated with insulin resistance in white European and American
populations, and low cardiorespiratory fitness is an independent
predictor of type 2 diabetes risk [39]. Cardiorespiratory fitness is
closely associated with skeletal muscle lipid oxidative capacity
[21223] and it is likely that fitness influences insulin sensitivity, at
least in part, via effects on muscle lipid metabolism [40,41]. In the
present report, adjusting ISI values for either VO2max or rate of fat
oxidation during exercise abolished the difference in insulin
sensitivity between the South Asian and European groups, and
strong correlations were evident between VO2max and fat
oxidation during exercise (r = 0.58 to 0.67, depending on units
of measurement, all p,0.0005). This supports the suggestion that
low oxidative capacity/capacity for fatty acid utilisation is a central
feature of the South Asian insulin resistance phenotype, and
highlights the fact that the lower cardiorespiratory fitness and
reduced capacity to oxidize fat in this group are likely to largely
reflect the same underlying mechanism. Interestingly, while South
Figure 7. Relationship between basal PKB Ser473 phosphorya-
tion and insulin sensitivity index.
doi:10.1371/journal.pone.0014197.g007
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Asians oxidised ,40% less fat than Europeans during submaximal
exercise, fat oxidation rates did not differ between the groups at
rest, and fat oxidation during exercise, but not at rest, correlated
with body insulin sensitivity. There are two potential reasons for
this. Firstly, whole-body fat oxidation during exercise largely
reflects fat oxidation in skeletal muscle. In the present study, fat
oxidation increased ,326 fold during exercise compared to rest
and this increase would almost exclusively be attributable to
changes in skeletal muscle. In contrast, skeletal muscle only
contributes about 20230% of resting energy expenditure [42],
thus whole-body fat oxidation at rest is to a large degree
determined by tissues other than skeletal muscle. Thus, if skeletal
muscle, rather than whole-body, fat oxidation is the key regulator
of insulin sensitivity, the relationship would be more clearly
revealed in whole-body measurements made during exercise
rather than at rest. Secondly, it is possible that a deficiency in
the capacity of muscle to oxidise fat becomes more evident when
energy demand is high, and is thus revealed during exercise. These
findings highlight the value of exercise testing in providing insights
into muscle metabolism in a relatively non-invasive manner.
However, in contrast to the observations made at the whole-
body level, South Asians did not exhibit lower expression of
oxidative and lipid metabolism genes in skeletal muscle biospies
than Europeans, and indeed expression of CPT1A and FASN
were higher in South Asians. In addition, other than a negative
correlation between expression of CPT1A and ISI in the South
Asians – the opposite direction of the expected association –
expression of none of these genes was related to whole-body
insulin sensitivity. Furthermore, the mtDNA to nDNA ratio, which
provides an index of mitochondrial biogenesis [43], did not differ
between the two groups. Our data therefore indicate that reduced
skeletal muscle expression of oxidative and lipid metabolism genes
does not explain the increased insulin resistance observed in South
Asians. These findings are broadly consistent with those of Nair
and colleagues reported that Asian Indians living in the USA had
increased skeletal muscle capacity for oxidative phosphorylation
and a higher mitochondrial DNA copy number than age- and
BMI-matched men of Northern European descent, concluding
that mitochondrial dysfunction could not account for the Asian
Indians’ greater insulin resistance [9]. Thus, it seems likely that the
reduced capacity of South Asians to oxidise fat during exercise
represents a defect in substrate delivery to muscle, rather than in
mitochondrial capacity to oxidise lipids. In Europeans, capacity for
mitochondrial fat oxidation in ex vivo muscle biopsy samples has
been shown to correlate strongly with whole-body fat oxidation
during sub-maximal exercise (but not at rest) [21]; this is consistent
with observations in the present study where positive correlations
were observed between skeletal muscle expression of oxidative and
lipid metabolism genes and fat oxidation during submaximal
exercise in the European group. However, strikingly, this pattern
was reversed in the South Asian group where negative correlations
were observed between skeletal muscle gene expression and fat
oxidation during exercise, and significant interactions in the
relationships between skeletal muscle gene expression and fat
oxidation during exercise were evident between the European and
South Asian groups. Thus, the South Asians with the highest
expression of oxidative and lipid metabolism genes oxidised the
least fat during exercise. Conceivably, this might reflect a
compensatory adaptation within muscle in response to impaired
microvascular perfusion leading to reduced fuel delivery. While we
have no data from the present study to support this suggestion,
South Asian men have been shown to have impaired endothelial
function in forearm resistance vessels [44] and reduced nitric oxide
bioavailability both at rest and during exercise [45], which would
be consistent with this hypothesis. Furthermore, there is clear
evidence that skeletal muscle oxidative capacity [46248], capacity
for fat utilisation [47,49] and insulin sensitivity [50252], are
governed not only by mitochondrial function, but also capillary
density and recruitment. Clearly, further study is now needed to
determine whether the increased insulin resistance and reduced
ability to oxidise fat in South Asians, is a consequence of
impairments in vascular function.
It is important to recognise that it is the mismatch between fatty
acid mobilisation and oxidation, rather than a low ability of
muscle to oxidise fat per se, which can lead to insulin resistance.
Recent studies have shown improvements in insulin sensitivity
with weight loss (which reduces fatty acid mobilisation [53]), in the
absence of changes in oxidative capacity or fatty acid oxidation
rates [53255], and have shown that increasing fatty acid
mobilisation by lipid infusion can abolish improvements in insulin
sensitivity elicited by exercise training, despite fatty acid oxidation
rates remaining elevated [53]. Thus, capacity for fatty acid
oxidation clearly only provides one part of the story, and further
study is needed to determine whether differences in fatty acid
mobilisation exist between South Asians and Europeans that may
contribute to the greater insulin resistance in the former group.
To the best of our knowledge, there have been no previously
published data comparing insulin signalling molecule expression
between any ethnic groups. Our novel data reveal that, in
unadjusted analysis, South Asians had significantly lower protein
expression of IRS-1, the p85 subunit of PI3K, PKB and basal PKB
Ser473 phosphorylation. IRS-1 is the principal IRS involved in
muscle insulin-stimulated glucose transport [56]. However, it is
unclear from the literature the extent to which altered IRS-1
expression is a characteristic of insulin resistant conditions in
humans. While reduced IRS-1 expression has been reported in
muscle of individuals with type 2 diabetes or obese subjects
[57,58], other studies have reported no difference in muscle IRS-1
expression in subjects with polycystic ovary syndrome (PCOS) [59]
insulin resistance [60], or type 2 diabetes [61], implying that
changes in the insulin signalling pathway downstream of IRS-1
may play a more important role in human insulin resistance. The
present data imply reduced IRS-1 signalling in South Asians,
which may manifest as impaired insulin-stimulated glucose
transport and a degree of insulin resistance in the muscle,
although this did not correlate significantly with our whole-body
measurement of insulin sensitivity. However, it is probable that
this reduced IRS-1 expression is simply a consequence of the
greater adiposity in the South Asian group, rather than a
fundamental difference in the properties of South Asians’ skeletal
muscle, as the difference was abolished after adjustment for
adiposity.
Our data also revealed lower expression of p85, yet unaltered
expression of p110b subunit of PI3K in the muscles of South
Asians compared to Europeans. Furthermore, the difference
persisted after adjustment for age, BMI and fat mass, implying a
Figure 8. Relationships between exercise fat oxidation and skeletal muscle expression of oxidative and lipid metabolism genes.
Significant correlations (p,0.05) are denoted by an asterix. P (int) signifies p-value for interaction in relationship between gene expression and fat
oxidation during exercise between European and South Asian groups.
doi:10.1371/journal.pone.0014197.g008
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fundamental difference in these aspects of insulin signalling
between South Asian and European skeletal muscle. The
implications, however, of altered PI3K p85 subunit expression
on insulin resistance are somewhat unclear in the literature, in
which the majority of studies have reported increased p85
expression to be associated with insulin resistance in human
muscle and animals [62265] and downregulation of p85 has been
reported to reverse the inhibition of insulin-stimulated glucose
transport in 3T3-L1 adipocytes caused by constitutively active
PKB [66]. In contrast, reduced p85 expression has also been
reported to be associated with obesity in a single study in placenta
[67]. The reduction observed in South Asians in the current study
is, therefore, in disagreement with many studies of insulin-resistant
cohorts, yet this may reflect the requirement for an optimal level of
p85 expression, whereby increased or decreased expression both
have detrimental consequences in terms of insulin sensitivity.
PKB exists as three isoforms, a (Akt1), b (Akt2) and c (Akt3),
and studies in knockout mice have indicated that PKBb is the
principal isoform regulating glucose homeostasis [68,69]. Impaired
insulin-stimulated PKB phosphorylation/activity has been ob-
served in skeletal muscle from subjects with type 2 diabetes or
PCOS [70272], yet other studies have reported no significant
difference in insulin-stimulated PKB activity or phosphorylation in
skeletal muscle of subjects with type 2 diabetes [63,73,74]. In the
present study, PKB expression and phosphorylation at Ser473 was
assessed with antibodies that do not distinguish between the
different isoforms. Intriguingly, PKB protein expression was
,50% lower in South Asians than Europeans, although
adjustment for age, BMI and fat mass, reduced this to borderline
statistical significance (p = 0.054). Furthermore, basal Ser473
phosphorylation of PKB was over 60% lower in South Asians, a
difference that persisted after adjustment for age, BMI and fat
mass. In addition, expression correlated significantly with whole-
body insulin sensitivity. The increased basal Ser473 phosphory-
lation observed in Europeans is unlikely to be a consequence of
endogenous insulin associated with the muscle biopsies after
washing, as South Asians exhibited higher fasting insulin
concentrations. In addition, basal PKB serine 473 phosphorylation
correlated strongly and significantly with whole-body fat oxidation
rates during exercise, suggesting that differences in capacity for fat
oxidation between Europeans and South Asians may influence
insulin sensitivity via effects at this point in the insulin signalling
pathway. In contrast to our findings on PKB, there were no
differences between South Asian and European muscle in protein
expression of cytosolic or microsomal PKC b1, which negatively
regulates insulin signalling [75], suggesting that PKC b1 does not
underlie the increased skeletal muscle insulin resistance observed
in South Asians.
This study is not without limitations. We assessed insulin
sensitivity from glucose and insulin responses to an oral glucose
tolerance test, rather than using the gold-standard euglycaemic
hyperinsulinaemic clamp. However, the insulin sensitivity index
we used correlates well with clamp-derived measures of insulin
sensitivity [37], has been widely accepted in the literature (.1000
citations in last decade), and was in our data set associated with
skeletal muscle insulin signalling. In addition, we only assessed
expression of insulin signalling proteins in the basal state – i.e.
signalling protein expression in response to fasting insulin
concentrations – and in response to maximal insulin stimulation.
While the direction of the differences in expression in the basal
data between South Asians and Europeans precludes potential
confounding by differences in fasting insulin concentrations (South
Asians had reduced signalling despite a tendency for higher insulin
concentrations), this study does not provide data on insulin
signalling across the range of physiological insulin doses and
further study is needed to ascertain whether insulin signalling
differs between South Asians and Europeans at insulin doses
between basal and maximal. We also only measured gene
expression of oxidative and lipid metabolism genes in skeletal
muscle. None of these was lower in the South Asians than the
Europeans, indicating that transcription of these genes is not
defective in South Asian muscle, but further study is needed to
determine whether differences in protein levels or activity of these
enzymes exist between South Asian and European skeletal muscle.
Finally, although the men were extensively phenotyped, we did
not directly determine IMTG or skeletal muscle concentrations of
lipid intermediates in this study and further investigation is needed
to ascertain the extent to which these differ between South Asians
and Europeans, and how they relate to capacity for fat oxidation
during exercise and insulin sensitivity.
In summary, the present novel observations indicate that South
Asians have reduced cardiorespiratory fitness and capacity for fat
oxidation during exercise compared to matched Europeans, and
these factors are associated with their lower insulin sensitivity,
independent of adiposity, both at a whole body level and at the
level of skeletal muscle PKB Ser473 phosphorylation. In
particular, reduced basal PKB Ser473 phosphorylation appears
to be an innate feature of South Asian, compared to European,
muscle which is related to insulin resistance at the whole body
level. However the reduced capacity for fat oxidation during
exercise was not reflected in reduced skeletal muscle expression of
oxidative and lipid metabolism genes, and the relationship
between expression of these genes and whole-fat oxidation during
exercise in South Asians was negative. This indicate that reduced
skeletal muscle expression of oxidative and lipid metabolism genes
does not explain the increased insulin resistance observed in South
Asians, and further investigation is needed to elucidate the
mechanisms underpinning the reduced capacity for fat oxidation
in South Asians and how this relates to their reduced insulin
sensitivity.
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